Meet CENTOGENE Headquarters


Founded in 2006, CENTOGENE is led by a diverse team of medical experts, industry pioneers, and healthcare investors. Our collective mission: Enabling the cure of 100 rare diseases in 10 years.

Leadership Team  Supervisory Board

Leadership Team

Chief Executive Officer

Kim Stratton

Kim Stratton

Chief Executive Officer

Kim serves as CENTOGENE’s Chief Executive Officer.

Kim has more than 25 years’ global […]

Maximilian Schmid, M.D., CENTOGENE’s Chief Commercial Officer Diagnostics

Maximilian Schmid, M.D.

Chief Commercial Officer – Diagnostics

Max serves as CENTOGENE’s Chief Commercial Officer Diagnostics. Bringing over two […]

Prof. Peter Bauer,  M.D., CENTOGENE's Chief Genomic Officer

Prof. Peter Bauer, M.D.

Chief Genomic Officer

Prof. Peter Bauer, M.D., serves as CENTOGENE's Chief Genomic Officer, where he combines […]

Patrice P. Denèfle, Ph.D., CENTOGENE’s Chief Scientific Officer

Patrice P. Denèfle, Ph.D.

Chief Scientific Officer

Patrice P. Denèfle serves as CENTOGENE’s Chief Scientific Officer. Within this role, he […]

Nathalie Daste, CENTOGENE’s Chief Human Resources Officer

Nathalie Daste

Chief Human Resources Officer

Bringing extensive experience in organization and capability building in the healthcare […]

Miguel Coego Rios, CENTOGENE’s Chief Financial Officer

Miguel Coego Rios

Interim Chief Financial Officer and EVP Finance & Legal

Miguel Coego Rios is an experienced senior executive with broad expertise in finance […]

Florian Vogel, Ph.D., CENTOGENE’s Chief Process Officer

Florian Vogel, Ph.D.

Chief Process Officer

Dr. Florian Vogel currently serves as the Chief Process Officer at CENTOGENE. Within […]


Individuals in the CENTOGENE Biodatabank


Collected biosamples


Active physicians in our network


Genes covered in testing portfolio

Top Company News

Newly established WGS recommendations published in the European Journal of Human Genetics

Company management will present in the virtual track at the H.C. Wainwright Global Investment Conference being held May 23–26, 2022, and invites…

Accelerating the path from diagnosis to available treatments for rare metabolic and rare neurodegenerative diseases